A recent in vitro study addressed potential pathways of Gal3ST1 gene overexpression in RCC and identified Gal3ST1 as a novel hypoxia-inducible factor (HIF) -mediated gene35. This evidence concerns the gene GAL3ST1 and renal cell adenocarcinoma.